Radiopharmaceuticals - San Francisco VA

Amendment / Modification

• The deadline for receipt of offers has been extended.

• The new Hour & Date for Receipt of Quotes is 05-21-2026 at 11:00 AM Pacific Time.

• The previous deadline was 05-18-2026.

• The deadline for Questions/RFIs has passed and is not extended.

• There are no other changes to the solicitation as a result of this amendment.

• Item 11: "THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS" - specifically the due date for receipt of offers.

• Proposal submission deadline extended to 05-21-2026 at 11:00 AM Pacific Time.

• Bidders must acknowledge receipt of this amendment.

• Failure to acknowledge receipt by the new deadline may result in offer rejection.

Solicitation / RFP / RFQ

This solicitation seeks offers for Radiopharmaceuticals for the Department of Veterans Affairs, specifically for the VA Medical Center at San Francisco. The contract will be an Indefinite Delivery Indefinite Quantity (IDIQ) type, with a potential five-year period of performance.

• Provision of NON-High Enriched Uranium (HEU) Derived Medical Isotopes when commercially available.

• Prepared single unit doses of radiopharmaceuticals and associated materials.

• Compliance with Nuclear Regulatory Commission, Department of Transportation, FDA, OSHA, and Joint Commission standards.

• Bar code compatibility with NMIS software.

• Radioactive material packaging must be clearly labeled "RADIOACTIVE".

• Deliveries must be completed prior to dose calibration time.

• STAT orders must arrive within two hours of placement.

• Contract Type: IDIQ

• Period of Performance: Five ordering periods, from 10/1/2026 to 9/30/2031.

• Guaranteed Minimum Award: $1,000.00

• Maximum Aggregate Value: $875,000.00

• Offers must be submitted via email to leah.smith@va.gov by 05-18-2026, 11:00 AM PDT.

• Requests for Information (RFI) must be submitted two (2) business days prior to closing.

• Quotes must include manufacturer, part number, country of origin, proof of Nuclear Regulatory Commission licensing, and any deviations from requested nuclides/doses.

• Evaluation will be based on Technical factors, Distance from Station (for STAT delivery capability), and Price.

• The Government will rate quotes that meet or exceed requirements more favorably.

• This acquisition is an unrestricted solicitation.

• NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing)

• Size Standard: 1300 Employees

• The solicitation references an "Items List.xls" for detailed item information and pricing.

• Offerors must provide distance from their facility to the San Francisco VA address.

• Trade Agreements Certificate completion is required if applicable.

Form / Attachment / Pricing Sheet

This document is an itemized list of radiopharmaceuticals and related kits required for various medical imaging procedures. It appears to be a pricing or requirements sheet that outlines specific nuclides, their doses, estimated quantities, and potentially unit prices, organized by ordering period.

• Nuclide: The specific radioactive isotope and chemical compound (e.g., Tc99m Macroaggregated Albumin, I-131 Nal).
• Dose: The required radioactive dosage for administration (e.g., 7 mCi, 200 uCi capsule).
• Estimated Quantity (EST QTY): The projected number of units needed.
• Manufacturer & Part #: Fields for supplier-specific information (left blank in provided data).
• Country of Origin (COO): Field for origin information (left blank in provided data).
• Unit Price: Field for pricing information (left blank in provided data).
• Ordering Periods: The list is broken down into five distinct ordering periods, each spanning one year from October 1st to September 30th, covering 2026 through 2031.

This document details the specific types and quantities of radiopharmaceuticals and kits that may be procured. Bidders should review this list to understand the product requirements, potential volumes, and the timeframe for potential orders. It serves as a basis for understanding the scope of potential supply needs for these medical isotopes over a multi-year period.